I. Petekkaya Et Al. , "Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine," JOURNAL OF BUON , vol.17, no.4, pp.796, 2012
Petekkaya, I. Et Al. 2012. Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine. JOURNAL OF BUON , vol.17, no.4 , 796.
Petekkaya, I., Gezgen, G., Roach, E. C., Solak, M., Altundag, K., & Gullu, I., (2012). Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine. JOURNAL OF BUON , vol.17, no.4, 796.
Petekkaya, I. Et Al. "Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine," JOURNAL OF BUON , vol.17, no.4, 796, 2012
Petekkaya, I. Et Al. "Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine." JOURNAL OF BUON , vol.17, no.4, pp.796, 2012
Petekkaya, I. Et Al. (2012) . "Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine." JOURNAL OF BUON , vol.17, no.4, p.796.
@article{article, author={I. Petekkaya Et Al. }, title={Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine}, journal={JOURNAL OF BUON}, year=2012, pages={796} }